Company Filing History:
Years Active: 2021
Title: Anxhela Kole: Innovator in Chimeric Protein Purification
Introduction
Anxhela Kole is a prominent inventor based in Quincy, MA (US). She has made significant contributions to the field of biochemistry, particularly in the purification of chimeric proteins. Her innovative work has the potential to enhance therapeutic applications in medicine.
Latest Patents
Anxhela Kole holds a patent for the "Purification of chimeric FVIII molecules." This invention focuses on methods for purifying a chimeric protein by subjecting it to factor VIII-specific affinity chromatography and anion exchange chromatography (AEX). The chimeric protein, which includes a factor VIII protein or a fragment thereof, demonstrates improved factor VIII activity when purified using her methods. She has 1 patent to her name.
Career Highlights
Anxhela is currently employed at Bioverativ Therapeutics Inc., where she continues to advance her research in protein purification. Her work is crucial in developing therapies for hemophilia and other related disorders.
Collaborations
Anxhela collaborates with talented professionals in her field, including her coworkers Lily Zhu and John D Kulman. Their combined expertise fosters a productive research environment that drives innovation.
Conclusion
Anxhela Kole's contributions to the purification of chimeric proteins represent a significant advancement in biochemistry. Her innovative methods have the potential to improve therapeutic outcomes for patients, showcasing her dedication to scientific progress.